Cargando…
Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
Alzheimer’s disease (AD) is the most common type of dementia which characterized by a progressive loss of memory and cognitive function due to degeneration of synapses and axons. Currently, there is no cure for AD. Deposition of extracellular amyloid-β (Aβ) plaques and intracellular tau neurofibrill...
Autores principales: | Liu, Jie, Li, Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713911/ https://www.ncbi.nlm.nih.gov/pubmed/31507373 http://dx.doi.org/10.3389/fnmol.2019.00203 |
Ejemplares similares
-
Bibliometric analysis of research on Alzheimer’s disease and non-coding RNAs: Opportunities and challenges
por: Fei, Xinxing, et al.
Publicado: (2022) -
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
por: Hemonnot, Anne-Laure, et al.
Publicado: (2019) -
Targeting Autophagy to Treat Cancer: Challenges and Opportunities
por: Lim, Junghyun, et al.
Publicado: (2020) -
Defective Autophagy and Mitophagy in Aging and Alzheimer’s Disease
por: Tran, Michael, et al.
Publicado: (2021) -
Role of Aducanumab in the Treatment of Alzheimer’s Disease: Challenges and Opportunities
por: Vaz, Miguel, et al.
Publicado: (2022)